Related by context. All words. (Click for frequent words.) 70 advanced adenomas 68 pneumonectomy 68 biochemical recurrence 67 Adjuvant chemotherapy 67 postoperative chemotherapy 67 pelvic lymphadenectomy 67 postoperative mortality 67 multivariate analyzes 67 preoperative chemotherapy 67 Radical prostatectomy 66 cystectomy 66 neoadjuvant therapy 66 curative resection 66 postintervention 66 resectable 66 radical nephrectomy 66 adjuvant radiotherapy 66 nodal metastasis 66 postoperative complication 66 lung resections 66 oncologic outcomes 66 liver resection 65 medically inoperable 65 locoregional recurrence 65 salpingo oophorectomy 65 lymphadenectomy 65 clinically localized prostate 65 postoperative morbidity 65 perioperative mortality 65 pCR 65 androgen deprivation 65 CTEPH 65 Postoperative complications 65 underwent surgical resection 65 cytoreduction 65 Aspergillus infections 65 lung resection 65 STRIDE PD 65 LV dysfunction 65 CR nPR 65 nonoperative treatment 64 thromboprophylaxis 64 UPPP 64 pulmonary dysfunction 64 hip resurfacing arthroplasty 64 CIN3 64 nondiabetic patients 64 cytoreductive surgery 64 conventional angiography 64 pT3 64 hepatic metastases 64 renal cell carcinomas 64 esophagectomy 64 logistic regression analysis 64 chemoradiation therapy 64 completely resected 64 AGILECT R 64 underwent resection 64 invasive ductal breast cancer 64 relapsed MM 64 cerebral angiography 64 hematopoietic cancers 64 malabsorptive 64 stage IIIb IV 64 renal tumors 64 multivariable analysis 64 HER2 positive cancers 64 thoracoscopic lobectomy 64 ximelagatran 64 debulking surgery 64 sentinel lymph node biopsy 64 HER2 expression 64 mucinous 64 intravesical therapy 64 perioperative morbidity 64 K ras mutations 64 SUVmax 63 radioiodine therapy 63 intravenous bisphosphonates 63 radical cystectomy 63 perioperative complications 63 Zevalin consolidation 63 androgen suppression 63 Tumor Response 63 wedge resection 63 adenoidectomy 63 advanced adenoma 63 baseline LDH 63 nonischemic 63 colorectal adenoma 63 oral anticoagulation 63 benign nodules 63 mcg albinterferon alfa 2b 63 locoregional 63 Hurthle cell 63 concurrent chemoradiation 63 resections 63 Cardiopulmonary bypass 63 HBeAg negative 63 ALND 63 malignant pleural mesothelioma 63 histologic subtype 63 malignant polyps 63 paclitaxel eluting stents 63 angiographic restenosis 63 laparoscopically assisted 63 dysglycemia 63 carotid stenosis 63 postoperative pulmonary 63 pT2 63 CIMZIA ™ 63 extrapleural pneumonectomy 63 LAGB 63 percutaneous drainage 63 SLNB 63 serous ovarian cancer 63 GISTs 63 malignant neoplasm 63 preoperative PSA 63 intestinal metaplasia 63 mutated K ras 63 Radiofrequency ablation 63 follicular lymphomas 63 Kaplan Meier analysis 63 recurrent glioblastoma multiforme 63 cytoreductive nephrectomy 63 lymph node dissection 63 skeletal metastases 63 chemoembolization 63 nodal metastases 63 Breast conserving 63 LVRS 63 percutaneous vertebroplasty 63 nephron sparing surgery 63 adrenalectomy 62 axillary node 62 ICD implantation 62 revascularization procedure 62 nonmetastatic 62 venous thromboembolism VTE prophylaxis 62 biochemical relapse 62 transesophageal echocardiography 62 ALT elevation 62 overt hypothyroidism 62 advanced neoplasia 62 Circulating tumor cells 62 HER2 overexpression 62 BRCA2 mutation carriers 62 ductal carcinomas 62 metastatic RCC 62 chemotherapeutic regimens 62 adjuvant therapies 62 prostate carcinoma 62 immunocompetent 62 metastatic lung cancer 62 oral Hycamtin 62 liver metastasis 62 underwent radical prostatectomy 62 nephrectomy 62 axillary lymph node dissection 62 kidney allograft 62 echocardiographic parameters 62 HER2 positivity 62 elevated LDH 62 prognostic variables 62 graft dysfunction 62 BEXXAR Therapeutic Regimen 62 dacarbazine chemotherapy 62 total thyroidectomy 62 Surgical resection 62 intraoperative complications 62 TNF blocker therapy 62 femoral neck fracture 62 colorectal carcinomas 62 haematologic 62 LVNC 62 hematologic toxicity 62 adenomatous polyps 62 pancreatic adenocarcinoma 62 hepatorenal syndrome 62 hepatocellular carcinomas 62 external beam radiotherapy 62 epidural analgesia 62 axillary lymph nodes 62 Ebstein anomaly 62 T1c 62 adenoma recurrence 62 metastatic neuroendocrine tumors 62 chemoradiotherapy 62 placebo dexamethasone 62 upper endoscopy 62 retransplantation 62 pulmonary metastases 62 spiral computed tomography 62 euthymic patients 62 hepatic resection 62 colorectal carcinoma 62 Surgical excision 62 retrospective cohort 62 urothelial carcinoma 62 nephrectomies 62 Cystectomy 62 rebleeding 62 IPAH 62 biopsied breast 62 HoLEP 62 undergone radical prostatectomy 62 prostate cancer CaP 62 CP CPPS 62 PSA nadir 62 hemorrhagic complications 62 tumor histology 62 System IPSS 62 cranial irradiation 62 lipid lowering agents 62 aortic insufficiency 62 contralateral breast 62 TEAEs 62 precancerous polyp 62 F FDG PET 62 carcinoids 62 recurrent VTE 62 intra abdominal abscess 62 bronchogenic carcinoma 62 Papillary 62 adenomyosis 62 mediastinitis 62 liver transplant recipients 62 adverse cytogenetics 62 genotypic resistance 62 colon resection 62 urolithiasis 62 thymectomy 62 angiographically 62 hamartomas 62 gestational diabetes mellitus 62 XELOX 62 amenorrhoea 62 Carotid stenting 62 percutaneous biopsy 62 splenic 61 pegylated liposomal doxorubicin 61 intracranial hemorrhage ICH 61 revascularization procedures 61 methotrexate therapy 61 adnexal mass 61 Lung transplantation 61 duplex ultrasonography 61 tumor resection 61 thyrotropin levels 61 extramedullary 61 axillary node dissection 61 TRUS biopsy 61 replacement TAVR 61 distant metastases 61 percutaneous transluminal coronary angioplasty 61 distant metastasis 61 PLX STROKE targeting 61 Doxil ® 61 allogeneic transplant 61 posttransplant 61 CsA 61 polypoid lesions 61 estimated glomerular filtration 61 squamous histology 61 Ectopia Cordis 61 metastatic GIST 61 lumbar disk herniation 61 non squamous NSCLC 61 atypical hyperplasia 61 pulmonary artery banding 61 precursor lesions 61 elevated serum creatinine 61 ADPKD 61 histopathologic examination 61 coronary stenosis 61 stratifying patients 61 corticosteroid therapy 61 definite stent thrombosis 61 histological subtype 61 postoperative infection 61 adrenocortical cancer 61 symptomatic VTE 61 LHRH receptor positive 61 lobectomy 61 aldosterone antagonist 61 EUS FNA 61 NMIBC 61 estimated GFR 61 follicular lymphoma FL 61 adenomatous 61 p = #.# [003] 61 macroalbuminuria 61 reduce serum phosphate 61 CIN2 + 61 beta carotene supplementation 61 osteosarcomas 61 ankle arthrodesis 61 carotid artery stenting CAS 61 unresectable tumors 61 Subgroup analyzes 61 hormone receptor negative 61 lymphovascular invasion 61 NNT = 61 dose ionizing radiation 61 operable breast cancer 61 R0 resection 61 lipid lowering therapy 61 portal vein thrombosis 61 meniscectomy 61 node metastases 61 MGUS 61 hepatectomy 61 clodronate 61 conventional coronary angiography 61 EDSS scores 61 pancreatectomy 61 obstructive coronary artery 61 PNH patients 61 nonoperative 61 pretest probability 61 mediastinal lymph nodes 61 microalbumin test 61 prospectively defined 61 colorectal neoplasms 61 chlorambucil 61 mesotheliomas 61 Operative mortality 61 full thickness plication 61 metachronous 61 hypoxemia 61 TMP SMX 61 gadolinium enhanced 61 extracapsular extension 61 invasive carcinomas 61 complete cytogenetic response 61 urine cytology 61 transvaginal sonography 61 transfemoral approach 61 pyrimethamine 61 paricalcitol 61 stage IIIB 61 hepatic cirrhosis 61 cisplatin resistant 61 OPCAB 61 CYPHER Stent 61 QVAR R 61 LNG IUS 61 colorectal adenocarcinoma 61 partial nephrectomy 61 randomized controlled trials RCTs 61 TAVR 61 invasive carcinoma 61 histologically 61 multivariate logistic regression 60 periprocedural 60 TKAs 60 histologically proven 60 pyelonephritis 60 inotropic agents 60 HGPIN 60 metastatic bladder 60 lung metastases 60 colorectal liver metastases 60 endosonography 60 coronary revascularizations 60 pancreatic resection 60 imipenem 60 bilateral oophorectomy 60 % CI #.#-#.# [008] 60 corticosteroid dose 60 Kaplan Meier curve 60 chronic rhinosinusitis 60 thrombocytopenic 60 metastatic lesions 60 secondary efficacy endpoint 60 androgen ablation 60 Endothelial dysfunction 60 neoplastic lesions 60 amoxicillin clavulanate 60 renal cysts 60 chronic periodontitis 60 #F FDG PET 60 metastatic lymph nodes 60 logistic regression model 60 peritoneal carcinomatosis 60 neoadjuvant chemotherapy 60 acetabular fractures 60 cilostazol 60 nonfatal MI 60 surgically resectable 60 differentially expressed genes 60 FOSRENOL ® 60 Subgroup analysis 60 β blockers 60 squamous cell histology 60 APTIVUS r 60 grade cervical intraepithelial 60 B7 H3 60 carotid artery blockage 60 Baseline characteristics 60 edifoligide 60 nonsmall cell lung cancer 60 PASI scores 60 morphometric vertebral fractures 60 extracranial 60 parathyroidectomy 60 recurrent metastatic 60 ductal breast cancer 60 axillary lymph node 60 calcaneal fractures 60 IFN beta 60 Chronic pancreatitis 60 CC genotype 60 Adjuvant therapy 60 endarterectomy 60 histologically confirmed 60 beta blocker therapy 60 nonmelanoma skin cancers 60 PCA3 scores 60 Umbilical cord stem cells 60 multimodality therapy 60 MMSE scores 60 hepatic lesions 60 sirolimus stent 60 intact parathyroid hormone 60 endocrine therapies 60 subtrochanteric 60 anagrelide 60 micrometastases 60 unfavorable cytogenetics 60 TP# mutations 60 EBRT 60 radical retropubic prostatectomy 60 gefitinib Iressa 60 vaginal hysterectomy 60 dose Iluvien 60 femoral neck fractures 60 osteoporotic compression fractures 60 primary patency 60 neurologic outcomes 60 allogeneic HSCT 60 HNSCC 60 fibrinolytic therapy 60 conditional logistic regression 60 binary restenosis 60 aortic root replacement 60 malignant neoplasms 60 trabeculectomy 60 leiomyomas 60 FluCAM arm 60 graft occlusion 60 iodixanol 60 candidemia 60 unstable angina pectoris 60 Coronary artery bypass 60 myoma 60 hypermethylated 60 severe exacerbations 60 MACCE 60 transurethral resection 60 thyroglobulin 60 lung adenocarcinomas 60 ER CHOP 60 reinterventions 60 FDG-PET/CT 60 metastatic gastric 60 warfarin therapy 60 microdebrider 60 ICSI cycles 60 coinfected patients 60 familial pancreatic cancer 60 Immunohistochemical staining 60 stepwise logistic regression 60 chemoradiation 60 lymph node involvement 60 extracolonic findings 60 systemic corticosteroid 60 metaplasia 60 tumor recurrence 60 ejection fractions 60 allogeneic stem cell 60 APOE ε4 60 rFVIIa 60 epithelial tumors 60 renal cortical 60 fibrinolysis 60 esophageal resection 60 IV bisphosphonates 60 CYT# potent vascular disrupting 60 everolimus eluting stents 60 neurologic complications 60 renal allograft 60 loop diuretics 60 KRAS mutations occur 60 adjuvant radiation 60 virological response 60 Complication rates 60 aneurysmal subarachnoid hemorrhage 60 Thal Dex 60 pamidronate 60 Lymphocytic 60 urothelial cancer 60 lenalidomide dexamethasone 60 somatoform disorders 60 prostate TURP 60 postoperative complications 60 pleural mesothelioma 60 invasive coronary angiography 60 logistic regression models 60 Univariate analysis 60 curative therapy 60 TURP 60 segmentectomy 60 chorioamnionitis 60 QTc prolongation 60 airway responsiveness 60 recurrent DVT 60 noncardiac 60 BRCA1 mutation carriers 60 ischemic lesions 60 FDG PET scans 60 malignant lymphoma 60 nonpregnant women 60 HbA1C levels 60 plain radiographs 60 ABCB1 60 Carotid endarterectomy 60 symptomatic aortic stenosis 60 endoscopic resection 60 neoplasias 60 TURBT 60 Multivariate analysis 60 univariate analysis 60 HIV uninfected 60 catheter angiography 59 recanalization 59 ovarian carcinoma 59 atorvastatin #mg 59 oral diclofenac 59 posaconazole 59 helical CT 59 PSADT 59 STN stimulation 59 asymptomatic carotid stenosis 59 Hb A1C 59 glycated hemoglobin levels 59 Hepatocellular Carcinoma HCC 59 Poisson regression 59 mTOR inhibitors 59 bezafibrate 59 histologic examination 59 paroxysmal AF 59 immunosuppressive regimen 59 undergoing coronary angiography 59 gastroesophageal junction 59 axillary dissection 59 coronary revascularization 59 comorbid illnesses 59 acute aortic dissection 59 intima media thickness 59 nonobese 59 lymph node metastasis 59 needle aspiration 59 revascularizations 59 intraductal 59 breast carcinoma 59 bovine thrombin 59 microemboli 59 pericardial effusion 59 cT3 prostate cancer 59 VATS lobectomy 59 sarcomatoid 59 FDG PET imaging 59 glomerular filtration 59 mycophenolate mofetil 59 univariate analyzes 59 multivariate Cox 59 seminoma 59 polyp recurrence 59 surgical revascularization 59 % CI #.#-#.# [007] 59 arterial thromboembolic events 59 T2 lesions 59 gemcitabine carboplatin 59 preeclamptic 59 affective psychosis 59 antibiotic regimens 59 spirometric 59 Gliadel Wafer 59 intraobserver 59 preserved ejection fraction 59 therapeutic regimens 59 proliferative retinopathy 59 lymphocytosis 59 Flu Cy 59 CIMZIA TM certolizumab pegol 59 bone scintigraphy 59 Coronary artery bypass grafting 59 atelectasis 59 FOLFIRINOX 59 prospective multicenter study 59 aneuploidy screening 59 tibial plateau fractures 59 recurrent venous thromboembolism 59 adenotonsillectomy 59 electrical cardioversion 59 myocardial reperfusion 59 dose atorvastatin 59 shorter telomere length 59 thymoma 59 orchiectomy 59 BCR ABL mutations 59 transarterial 59 ORIF 59 ischemic cardiomyopathy 59 computed tomographic 59 clinically detectable 59 patients undergoing CABG 59 -#.# log# 59 FOLPI 59 ß blockers 59 undergoing CABG 59 ANCA associated 59 Squamous 59 malperfusion 59 Cardiotoxicity 59 preintervention 59 Vectibix monotherapy 59 clinicopathological features 59 microbiologically evaluable 59 tumoral 59 hepatoma 59 gadobutrol 59 seminomas 59 laparoscopic radical prostatectomy 59 AV grafts 59 schwannomas 59 paclitaxel cisplatin 59 fluvastatin 59 logistic regression analyzes 59 colorectal polyp 59 ancrod 59 nonobstructive CAD 59 cytogenic 59 methotrexate monotherapy 59 pulmonary metastasis 59 prospectively stratified 59 5-FU/LV 59 systolic dysfunction 59 RARP 59 metastatic colorectal 59 osteochondromas 59 HIPEC 59 Eisenmenger syndrome 59 core needle biopsy 59 removed laparoscopically 59 univariate 59 thromboembolic events 59 tenecteplase 59 resected pancreatic cancer 59 gp# vaccine 59 radical prostatectomy RP 59 multiple logistic regression 59 alkylating agents 59 ECLS 59 comparator arm 59 Coronary Artery Bypass Graft 59 LRTI 59 Immunohistochemical analysis 59 intravenous cyclophosphamide 59 peritoneal cancer 59 knee arthroplasty 59 zotarolimus 59 nonunions 59 histopathologic findings 59 basal cell carcinoma BCC 59 LIPUS 59 Leukemias 59 balloon brachytherapy 59 SYNTAX trial 59 psychiatric comorbidity 59 endometrial carcinoma 59 Multivariate logistic regression 59 transgene expression 59 thyroid nodule 59 unfractionated heparin UFH 59 thyroidectomy 59 EDSS score 59 pancreatic lung 59 eplerenone 59 excisional biopsy 59 papillary renal cell carcinoma 59 bladder tumors 59 serum thyroglobulin 59 astrocytomas 59 transfusion syndrome 59 sustained ventricular tachycardia 59 salmeterol fluticasone 59 mg BID dose 59 LTBI 59 CVD mortality 59 endometrial biopsy 59 differentiated thyroid 59 parous women 59 specific antigen PSA 59 venlafaxine XR 59 covariate 59 pleurodesis 59 IOP lowering 59 cutaneous squamous cell carcinoma 59 Heavy menstrual bleeding 59 lymph node removal 59 Inhaled nitric oxide 59 haematopoietic 59 liver biopsies 59 node dissection 59 atrophic gastritis 59 Hazard Ratio 59 anthracycline containing 59 malignant lesions 59 tumor necrosis 59 coronary arteriography 59 sirolimus eluting stents 59 tertile 59 paraganglioma 59 troponin T 59 median sternotomy 59 psychiatric comorbidities 59 KRAS mutations 59 GG genotype 59 carotid endarterectomy CEA 59 chemoresistant 59 pathologic examination 59 incisional 59 symptomatic intracranial hemorrhage 59 Non inferiority 59 artery stenting 59 bowel polyps 59 stent stenosis 59 5FU 59 median survivals 59 unresectable 59 reintubation 59 postoperative infections 59 glycoprotein IIb IIIa inhibitors 59 AA Amyloidosis 59 infective endocarditis 59 FOLFOX4 59 colonic polyps 59 complement inhibitor eculizumab 59 heterotaxy 59 NNRTI resistance 59 adenocarcinomas 59 Computed tomography 59 Carotid artery stenting 59 HBeAg seroconversion 59 RQ PCR 59 lymph node metastases 59 prevalences 59 salmeterol HFA MDI 59 AST ALT 59 thromboembolic 59 oxidized phospholipids 59 IV NSCLC 59 submandibular gland 59 acetabular fracture 59 esophageal gastric 59 E. faecalis 59 ovarian malignancy 59 idraparinux 59 reoperations 59 endoscopic remission 59 subgroup analyzes 59 nonalcoholic steatohepatitis 59 acetaminophen codeine 59 urothelial 59 Accelerated Partial Breast Irradiation 59 ritonavir boosted lopinavir 59 tumor excision 59 Renal Cell Carcinoma RCC 59 serum phosphorous 59 irbesartan 59 tuberculin skin testing 59 Coronary artery bypass graft 59 abdominal hysterectomy 59 International Prognostic Scoring 59 gastric adenocarcinoma 59 albumin excretion rate 59 dosimetric 59 H pylori 58 Erlotinib 58 acute cholecystitis 58 Relapsing remitting MS 58 p# mutations 58 micrometastasis 58 concomitant medications 58 ARB telmisartan 58 TNF antagonist 58 localized renal 58 epirubicin 58 hypervascular tumors 58 ASCUS 58 ertapenem 58 adjuvant therapy 58 KRAS oncogene 58 variceal bleeding 58 antiangiogenic therapy 58 scintigraphic 58 recurrent NSCLC 58 adjuvant tamoxifen 58 symptomatic paroxysmal AF 58 tigecycline 58 anemia hemoglobin 58 degenerative spondylolisthesis 58 pretransplant 58 aspirin clopidogrel 58 hemodynamically significant 58 calcineurin inhibitors 58 diskectomy 58 percutaneous intervention 58 chromosomal mutations 58 oophorectomy 58 gastroduodenal 58 octreotide LAR 58 invasive ductal 58 advanced hepatocellular carcinoma 58 arterial revascularization 58 GnRH agonists 58 % CI #.#-#.# [004] 58 gastrectomy 58 sacrocolpopexy 58 colorectal neoplasia 58 beam radiotherapy 58 leiomyoma 58 mammographically 58 T1a 58 Aortic stenosis 58 subclinical hyperthyroidism 58 perioperatively 58 transthoracic 58 clinico pathological 58 arterial occlusion 58 EGFR HER2 58 immunohistochemical analysis 58 radiographic findings 58 radiochemotherapy 58 tapentadol IR 58 NATRECOR R 58 liposomal doxorubicin 58 Carotid Revascularization Endarterectomy vs. 58 Adenomas 58 tamoxifen Nolvadex ® 58 glycated hemoglobin HbA1c 58 varicocele 58 angioplasty stenting 58 conformal radiotherapy 58 reperfusion therapy 58 nonalcoholic steatohepatitis NASH 58 invasive candidiasis 58 cytotoxic chemotherapy 58 endometriosis ovarian cysts 58 hsCRP levels 58 neoadjuvant treatment 58 DAS# remission 58 bypass grafting 58 underwent CABG 58 severe periodontitis 58 NSTE ACS 58 trans retinoic acid 58 diabetes mellitus DM 58 calculated creatinine clearance 58 operable pancreatic cancer 58 ALI ARDS 58 imatinib therapy 58 gemcitabine cisplatin 58 guaiac 58 vWD 58 sentinel nodes 58 MetS 58 metastatic malignant 58 timepoints 58 PCa 58 basal cell nevus syndrome 58 TMPRSS2 ERG fusion 58 preoperative diagnosis 58 multivariable Cox 58 occult metastases 58 carotid bruit 58 liver histology 58 grade gliomas 58 rFSH 58 multivariate regression analysis 58 chest radiography 58 VTE prophylaxis 58 congenital toxoplasmosis 58 intracranial hypertension 58 breast endometrial 58 TT genotype 58 pathologic fractures 58 malignant nodules 58 HbA 1c levels 58 endovascular repair 58 somatostatin analog 58 distal colon 58 endometrial hyperplasia 58 aromatase inhibitor therapy 58 SNP rs# [002] 58 sonographically guided 58 biliary tract cancer 58 neurosensory 58 pathologic diagnosis 58 IDH mutations 58 oropharyngeal cancer 58 protease inhibitor PI 58 autologous transplants 58 neuropathy sensory 58 KRAS mutation 58 differential gene expression 58 cytotoxic therapy 58 cytologically confirmed 58 conjugated equine estrogen 58 atherothrombotic disease 58 mL/min/#.# m 2 58 macrovascular complications 58 FDG PET 58 seminal vesicle invasion 58 intracranial atherosclerosis 58 alteplase 58 bronchoalveolar lavage 58 elevated transaminases 58 carotid endarterectomy 58 surgical excision 58 interferon ribavirin 58 CHAMPION PCI 58 multivariate adjustment 58 aortic calcification 58 KRAS status 58 breast cancer subtypes 58 probiotic supplementation 58 riociguat 58 μmol L 58 MDCT angiography 58 renal biopsy 58 proximal DVT 58 neurodevelopmental impairment 58 TNFa 58 varices 58 FLT3 mutations 58 bladder carcinoma 58 baseline FEV 58 estrogen receptor negative 58 arteriography 58 obstructive CAD 58 pulmonary embolism PE 58 EGFR mutation positive 58 inhaled bronchodilators 58 endobronchial 58 HBeAg positive patients 58 oral anticoagulant therapy 58 metformin monotherapy 58 antiemetics 58 Index CDAI 58 intensive statin therapy 58 elective PCI 58 RALP 58 meningiomas 58 hVISA patients 58 osteoid 58 PREZISTA r arm 58 obscure gastrointestinal bleeding 58 LHRH agonists 58 mutated KRAS 58 odds ratios ORs 58 thyrotropin 58 SLN biopsy 58 cardiac perfusion 58 BODE index 58 nadroparin 58 nulliparous women 58 mg kg dose 58 preoperative radiotherapy 58 autologous SCT 58 Avandia Actos 58 PITX2 methylation 58 response pCR 58 variceal hemorrhage 58 EXJADE 58 late onset hypogonadism 58 hepatitis C genotype 58 adriamycin 58 tipranavir ritonavir 58 lobular carcinomas 58 arterial thickening 58 nucleoside naive patients 58 BMD measurements 58 trimethoprim sulfamethoxazole 58 Phacoemulsification 58 cystoscopic